A leaked n8n API key is only the start. GitGuardian's research traces the full chain, from exposed tokens and weak keys to ...

AI coding agents can accelerate development, but they may also generate bloated code and technical debt. Learn where they ...

Generac accelerates area plant opening, eyes more sites for data unit © 2026 American City Business Journals. All rights ...

If you've ever wondered how to reuse configuration values or how to easily inject them into your code, then I have the perfect tool for you. It's not just a JSON replacement but something more ...

Back in 2023, Chris Lattner, creator of LLVM, and his team at Modular unveiled a new language called Mojo. Its syntax resembled Python, but it compiled to machine-native code and offered memory-safety ...

If vanilla AI image generators leave you feeling underwhelmed, it's time to play with the spicy stuff. I put the most popular NSFW options to the test so you can find the one that really hits the mark ...

I'm an independent creator passionate about building useful tools, simulations, and theories that make complex ideas more accessible. I explore the intersection of technology, education, and human ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...